IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii

Parasite Immunology

Volumn 26, Issue 5, 2004, Pages 229-236

  Wille, Ulrike ^a,b   Nishi, M ^a   Lieberman, L ^a   Wilson, E H ^a   Roos, D S ^a   Hunter, C A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Vaccine Research Center   (United States)

Author keywords

IL 10; Memory response; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; SULFADIAZINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PARASITE VIRULENCE; PARASITOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPERINFECTION; SURVIVAL RATE; TOXOPLASMA GONDII;

ANIMALS; ANTIPROTOZOAL AGENTS; BRAIN; FEMALE; HISTOCYTOCHEMISTRY; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; PERITONEAL CAVITY; PROTEIN SUBUNITS; STATISTICS, NONPARAMETRIC; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALIA; PROTOZOA; TOXOPLASMA GONDII;

EID: 7444272595     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00704.x     Document Type: Article

References (50)

1. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG & de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
2. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183-1186.
3. Meyaard L, Hovenkamp E, Otto SA & Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996; 156: 2776-2782.
4. Gerosa F, Paganin C, Peritt D, et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 1996; 183: 2559-2569.
5. Moore KW, de Waal Malefyt R, Coffman RL & O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
6. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M & Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178: 1041-1048.
7. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M & O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822.
8. Fiorentino DF, Bond MW & Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
9. Tripp CS, Wolf SF & Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993; 90: 3725-3729.
10. Willems F, Marchant A, Delville JP, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24: 1007-1009.
11. Buelens C, Willems F, Delvaux A, et al. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 1995; 25: 2668-2672.
12. Ding L, Linsley PS, Huang LY, Germain RN & Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-1234.
13. Poe JC, Wagner DH Jr, Miller RW, Stout RD & Suttles J. IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1 beta synthesis and rescue from apoptosis. J Immunol 1997; 159: 846-852.
14. Suttles J, Milhorn DM, Miller RW, Poe JC, Wahl LM & Stout RD. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (IL)-4 and IL-10 anti-inflammatory action. J Biol Chem 1999; 274: 5835-5842.
15. Koppelman B, Neefjes JJ, de Vries JE & de Waal Malefyt R. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997; 7: 861-871.
16. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
17. + T cells. J Immunol 1998; 160: 3188-3193.
18. Kuhn R, Lohler J, Rennick D, Rajewsky K & Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
19. Rennick DM, Fort MM & Davidson NJ. Studies with IL-10-/-mice: an overview. J Leukoc Biol 1997; 61: 389-396.
20. Berg DJ, Davidson N, Kuhn R, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996; 98: 1010-1020.
21. + T cells, but not B cells, mediate colitis in interleukin-10- deficient mice. J Exp Med 1996; 184: 241-251.
22. Deckert M, Soltek S, Geginat G, et al. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect Immun 2001; 69: 4561-4571.
23. Hunter CA, Ellis-Neyer LA, Slifer T, et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 1997; 158: 3311-3316.
24. Holscher C, Mohrs M, Dai WJ, et al. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun 2000; 68: 4075-4083.
25. Li C, Corraliza I & Langhorne J. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun 1999; 67: 4435-4442.
26. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J Immunol 1996; 157: 798-805.
27. Ellis-Neyer L, Grunig G, Fort M, Remington JS, Rennick D & Hunter CA. Role of IL-10 in regulation of T-cell-dependent and T-cell-independent mechanism of resistance. Infect Immun 1997; 65: 1675-1682.
28. Hoffmann KF, Cheever AW & Wynn TA. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 2000; 164: 6406-6416.
29. Wynn TA, Cheever AW, Williams ME, et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 1998; 160: 4473-4480.
30. Schopf LR, Hoffmann KF, Cheever AW, Urban JF Jr & Wynn TA. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J Immunol 2002; 168: 2383-2392.
31. Villegas EN, Wille U, Craig L, et al. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice. Infect Immun 2000; 68: 2837-2844.
32. Wille U, Villegas EN, Craig L, Peach R & Hunter CA. Contribution of IL-12 and the costimulatory signaling pathways CD28/B7 and CD40/CD40L to the development of a pathological T cell response in IL-10 deficient mice. Infect Immun 2002; 70: 6940-6947.
33. Suzuki Y, Orellana MA, Schreiber RD & Remington JS. Interferon gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988; 240: 516-518.
34. Suzuki Y, Conley FK & Remington JS. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infect Immun 1990; 58: 3050-3055.
35. Suzuki Y, Conley FK & Remington JS. Importance of endogenous IFN gamma for prevention of toxoplasmic encephalitis in mice. J Immunol 1989; 143: 2045-2050.
36. Black CM, Catterall JR & Remington JS. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ. J Immunol 1987; 138: 491-495.
37. McCabe RE, Luft BJ & Remington JS. Effect of murine interferon gamma on murine toxoplasmosis. J Infect Dis 1984; 150: 961-962.
38. Brinkmann V, Sharma SD & Remington JS. Different regulation of the L3T4-T cell subset by B cells in different mouse strains bearing the H-2k haplotype. J Immunol 1986; 137: 2991-2997.
39. Blewett DA, Miller JK & Harding J. Simple technique for the direct isolation of toxoplasma tissue cysts from fetal ovine brain. Vet Rec 1983; 112: 98-100.
40. Sharma SD, Mullenax J, Araujo FG, Erlich HA & Remington JS. Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 1983; 131: 977-983.
41. Hunter CA, Abrams JS, Beaman MH & Remington JS. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun 1993; 61: 4038-4044.
42. Conley FK & Jenkins KA. Immunohistological study of the anatomic relationship of toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect Immun 1981; 31: 1184-1192.
43. Wille U, Villegas EN, Striepen B, Roos DS & Hunter CA. Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol 2001; 23: 291-296.
44. Villegas EN, Elloso MM, Reichmann G, Peach R & Hunter CA. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. J Immunol 1999; 163: 3344-3353.
45. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
46. Belkaid Y, Hoffmann KF, Mendez S, et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001; 194: 1497-1506.
47. Hunter CA, Roberts CW & Alexander J. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol 1992; 22: 2317-2322.
48. + T lymphocytes in IFN-γ production and protective immunity induced by attenuated Toxoplasma gondii vaccine. J Immunol 1991; 146: 286-292.
49. Suzuki Y & Remington JS. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol 1988; 140: 3943-3946.
50. Wu CY, Kirman JR, Rotte MJ, et al. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 2002; 3: 852-858.